Risk Factor Analysis for 30-day Mortality After Surgery for Infective Endocarditis
The Thoracic and Cardiovascular Surgeon · 01.12.2024 · 72 (08) · 595-606
DOI: 10.1055/s-0044-1779709 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.12.2024. Verfasst von Jill Jussli-Melchers und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Universitatsklinikum Schleswig-Holstein, Kiel, Germany. Hauptthemen laut MEDLINE: Endocarditis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Infective endocarditis (IE) remains a challenging disease associated with high mortality. Several scores have been suggested to assess surgical risk. None was sufficiently adequate. We therefore analyzed risk factors for 30-day mortality.
Methods
A total of 438 consecutive patients had surgery for IE in our department between 2002 and 2020. Patients were divided into two groups, one consisting of 30-day survivors (362 patients; 82.6%) and one of nonsurvivors (76 patients; 17.4%). Logistic regression analysis on pre- and intraoperative risk factors was performed and the groups were compared by univariable analyses.
Results
Patients in mortality group were older (69 [58, 77] vs. 63 [50, 72] years; p < 0.001), EuroSCORE II was higher (24.5 [12.1, 49.0] vs. 8.95 [3.7, 21.2]; p < 0.001) and there were more females. More frequently left ventricular function (below 30%), preoperative acute renal insufficiency, chronic dialysis, insulin-dependent diabetes mellitus, NYHA-class IV (New York Heart Association heart failure class IV), and cardiogenic shock occurred. Patients in the mortality group were often intensive care unit patients (40.8 vs. 22.4%; p < 0.001) or had a preoperative stroke (26.3 vs. 16.0%; p = 0.033). In the nonsurvivor group Staphylococcus aureus was prevalent. Streptococcus viridans was common in the survivor group as was isolated aortic valve endocarditis (32.9 vs. 17.1%; p = 0.006). Prosthetic valve endocarditis (PVE) and abscesses occurred more often in nonsurvivors. In the logistic regression analysis, female gender, chronic dialysis, cardiogenic shock, and NYHA IV and from intraoperative variables PVE, cardiopulmonary bypass time, and mitral valve surgery were the strongest predictors for 30-day mortality.
Conclusion
This study indeed clearly indicates that significant risk factors for 30-day mortality cannot be changed. Nevertheless, they should be taken into account for preoperative counselling, and they will alert the surgical team for an even more careful management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiac Surgery, Universitatsklinikum Schleswig-Holstein, Kiel, Germany.
- Department for Cardiac Surgery, Justus Liebig Universitat Giessen Fachbereich Medizin, Gießen, Hessen, Germany.
- Department for Cardiac Surgery, Krankenhaus der Barmherzigen Brüder, Heart Center Trier, Trier, Germany.
Zitieren
APA
Jussli-Melchers, J., Friedrich, C., Mandler, K., Alosh, M. H., Salem, M. A., Schoettler, J., Cremer, J., & Haneya, A. (2024). Risk Factor Analysis for 30-day Mortality After Surgery for Infective Endocarditis. The Thoracic and Cardiovascular Surgeon, 72(08), 595-606. https://doi.org/10.1055/s-0044-1779709
Vancouver
Jussli-Melchers J, Friedrich C, Mandler K, Alosh MH, Salem MA, Schoettler J, et al. Risk Factor Analysis for 30-day Mortality After Surgery for Infective Endocarditis. The Thoracic and Cardiovascular Surgeon. 2024;72(08):595-606. doi:10.1055/s-0044-1779709
BibTeX
@article{JussliMelchers2024,
author = {Jussli-Melchers, Jill and Friedrich, Christine and Mandler, Kira and Alosh, Mohamad Hosam and Salem, Mohamed Ahmed and Schoettler, Jan and Cremer, Jochen and Haneya, Assad},
title = {Risk Factor Analysis for 30-day Mortality After Surgery for Infective Endocarditis},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2024},
volume = {72},
number = {08},
pages = {595--606},
doi = {10.1055/s-0044-1779709}
}
EUVIMED